This tutorial presents practical guidance on transforming various types of information
published in journals, or available online from government and other sources, into transition …

Novel cancer therapies are associated with survival patterns that differ from established
therapies, which may include survival curves that plateau after a certain follow-up time point …

Importance Axicabtagene ciloleucel, a chimeric antigen receptor T-cell therapy, represents a
new and potentially curative treatment option for B-cell lymphoma. It is expected to have …

Estimating heterogeneous treatment effects is an important problem across many domains.
In order to accurately estimate such treatment effects, one typically relies on data from …

Aims Accurately estimating mean survival after solid organ transplant (SOT) is crucial for
efficient healthcare resource allocation decisions. However, registry-based post-transplant …

Background Immune-checkpoint inhibitors may provide long-term survival benefits via a
cured proportion, yet data are usually insufficient to prove this upon submission to health …

Objectives Survival extrapolation of trial outcomes is required for health economic
evaluation. Generally, all-cause mortality (ACM) is modeled using standard parametric …

Background New immuno-oncology (IO) therapies that harness the immune system to fight
cancer call for a re-examination of the traditional parametric techniques used to model …

Policy makers worldwide use economic evaluation to inform decisions when allocating
limited healthcare resources. A critical part of this evaluation involves accurately estimating …

Survival analysis features heavily as an important part of health economic evaluation, an
increasingly important component of medical research. In this setting, it is important to …